Table 1. Associations between clinicopathological features and immune scores in 346 liver cancer patients.
Immune scores | ||||||
---|---|---|---|---|---|---|
Characteristics | Total | Low | Medium | High | χ2 value | p-value |
Sample sizes | 346 | 35 | 198 | 113 | ||
Age (y) | 6.16 | 0.63 | ||||
< 40 | 32 | 5 | 17 | 10 | ||
40–49 | 38 | 2 | 25 | 11 | ||
50–59 | 93 | 13 | 47 | 33 | ||
60–69 | 112 | 8 | 67 | 37 | ||
≥ 70 | 71 | 7 | 42 | 22 | ||
Tumor grade | 4.68 | 0.59 | ||||
G1 | 46 | 6 | 28 | 12 | ||
G2 | 169 | 12 | 98 | 59 | ||
G3 | 118 | 16 | 65 | 37 | ||
G4 | 13 | 1 | 7 | 5 | ||
Stage | 8.53 | 0.20 | ||||
Stage I | 171 | 12 | 96 | 63 | ||
Stage II | 85 | 8 | 49 | 28 | ||
Stage III | 84 | 14 | 49 | 21 | ||
Stage IV | 6 | 1 | 4 | 1 |
p < 0.05; difference was statistically significant.